The comparative pathology of genetically engineered mouse models for neuroendocrine carcinomas of the lung

Journal of Thoracic Oncology

Volumn 10, Issue 4, 2015, Pages 553-564

  Gazdar, Adi F ^a   Savage, Trisha K ^a   Johnson, Jane E ^a   Berns, Anton ^b   Sage, Julien ^c   Linnoila, R Ilona ^d   Macpherson, David ^e   Mcfadden, David G ^f   Farago, Anna ^f   Jacks, Tyler ^f   Travis, William D ^g   Brambilla, Elisabeth ^h  

^a UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^b NETHERLANDS CANCER INSTITUTE   (Netherlands)

^c STANFORD UNIVERSITY   (United States)

^d NATIONAL CANCER INSTITUTE   (United States)

^e Fred Hutchinson Cancer Research Center   (United States)

^f MASSACHUSETTS INSTITUTE OF TECHNOLOGY   (United States)

^g MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

^h HÔPITAL MICHALLON   (France)

Author keywords

Genetically engineered mouse models; Lung carcinoma; Neuroendocrine carcinomas; Non small cell lung cancer; Pathology; Small cell lung carcinoma

Indexed keywords

PROTEIN P130; PROTEIN P53; RETINOBLASTOMA PROTEIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CARCINOMA IN SITU; CELL DIFFERENTIATION; CELL HYPERPLASIA; COMPARATIVE STUDY; CONTROLLED STUDY; GENE DOSAGE; GENETICALLY ENGINEERED MOUSE STRAIN; LARGE CELL CARCINOMA; LARGE CELL NEUROENDOCRINE CARCINOMA; MOUSE; NON SMALL CELL LUNG CANCER; NONHUMAN; PRIORITY JOURNAL; PROMOTER REGION; RESPIRATORY EPITHELIUM; SMALL CELL LUNG CANCER; ANIMAL; CARCINOMA; ELECTRON MICROSCOPY; EXPERIMENTAL NEOPLASM; GENETIC ENGINEERING; GENETICS; KNOCKOUT MOUSE; LUNG; LUNG TUMOR; PATHOLOGY; PROCEDURES; TUMOR CELL CULTURE; ULTRASTRUCTURE;

ANIMALS; CARCINOMA, NEUROENDOCRINE; GENETIC ENGINEERING; LUNG; LUNG NEOPLASMS; MICE; MICE, KNOCKOUT; MICROSCOPY, ELECTRON; NEOPLASMS, EXPERIMENTAL; TUMOR CELLS, CULTURED;

EID: 84929949436     PISSN: 15560864     EISSN: 15561380     Source Type: Journal    
DOI: 10.1097/JTO.0000000000000459     Document Type: Article

References (46)

1. Herbst RS, Heymach JV, Lippman SM, Lung cancer. N Engl J Med 2008 359 1367 1380
2. Minna JD, Kurie JM, Jacks T, A big step in the study of small cell lung cancer. Cancer Cell 2003 4 163 166
3. Travis W, Brambilla E, Müller-Hermelink H, World Health Organization Classification of Tumours: Tumours of the Lung, Pleura, Thymus and Heart-Pathology and Genetics 2004 Lyon IARC Press
4. Brambilla E, Travis WD, Colby TV, Corrin B, Shimosato Y, The new World Health Organization classification of lung tumours. Eur Respir J 2001 18 1059 1068
5. Swarts DR, Ramaekers FC, Speel EJ, Molecular and cellular biology of neuroendocrine lung tumors: Evidence for separate biological entities. Biochim Biophys Acta 2012 1826 255 271
6. Sutherland KD, Berns A, Cell of origin of lung cancer. Mol Oncol 2010 4 397 403
7. Park KS, Liang MC, Raiser DM, Characterization of the cell of origin for small cell lung cancer. Cell Cycle 2011 10 2806 2815
8. Gazdar AF, Brambilla E, Preneoplasia of lung cancer. Cancer Biomark 2010 9 385 396
9. Rizvi SM, Goodwill J, Lim E, The frequency of neuroendocrine cell hyperplasia in patients with pulmonary neuroendocrine tumours and non-neuroendocrine cell carcinomas. Histopathology 2009 55 332 337
10. Travis WD, Advances in neuroendocrine lung tumors. Ann Oncol 2010 21 vii65 vii71
11. Rudin CM, Durinck S, Stawiski EW, Comprehensive genomic analysis identifies SOX2 as a frequently amplified gene in small-cell lung cancer. Nat Genet 2012 44 1111 1116
12. Peifer M, Fernández-Cuesta L, Sos ML, Integrative genome analyses identify key somatic driver mutations of small-cell lung cancer. Nat Genet 2012 44 1104 1110
13. Joshi M, Ayoola A, Belani CP, Small-cell lung cancer: An update on targeted therapies. Adv Exp Med Biol 2013 779 385 404
14. Gazdar AF, Girard L, Lockwood WW, Lam WL, Minna JD, Lung cancer cell lines as tools for biomedical discovery and research. J Natl Cancer Inst 2010 102 1310 1321
15. Meuwissen R, Linn SC, Linnoila RI, Zevenhoven J, Mooi WJ, Berns A, Induction of small cell lung cancer by somatic inactivation of both Trp53 and Rb1 in a conditional mouse model. Cancer Cell 2003 4 181 189
16. Schaffer BE, Park KS, Yiu G, Loss of p130 accelerates tumor development in a mouse model for human small-cell lung carcinoma. Cancer Res 2010 70 3877 3883
17. Cui M, Augert A, Rongione M, PTEN is a potent suppressor of small cell lung cancer. Mol Cancer Res 2014 12 654 659
18. McFadden DG, Papagiannakopoulos T, Taylor-Weiner A, Genetic and clonal dissection of murine small cell lung carcinoma progression by genome sequencing. Cell 2014 156 1298 1311
19. Howe MC, Chapman A, Kerr K, Dougal M, Anderson H, Hasleton PS, Neuroendocrine differentiation in non-small cell lung cancer and its relation to prognosis and therapy. Histopathology 2005 46 195 201
20. Linnoila RI, Piantadosi S, Ruckdeschel JC, Impact of neuroendocrine differentiation in non-small cell lung cancer. The LCSG experience. Chest 1994 106 367S 371S
21. Pelosi G, Pasini F, Sonzogni A, Prognostic implications of neuroendocrine differentiation and hormone production in patients with Stage I nonsmall cell lung carcinoma. Cancer 2003 97 2487 2497
22. Ionescu DN, Treaba D, Gilks CB, Nonsmall cell lung carcinoma with neuroendocrine differentiation-An entity of no clinical or prognostic significance. Am J Surg Pathol 2007 31 26 32
23. Gazdar AF, Kadoyama C, Venzon D, Association between histological type and neuroendocrine differentiation on drug sensitivity of lung cancer cell lines. J Natl Cancer Inst Monogr 1992 191 196
24. Travis WD, Lung tumours with neuroendocrine differentiation. Eur J Cancer 2009 45 251 266
25. Jones MH, Virtanen C, Honjoh D, Two prognostically significant subtypes of high-grade lung neuroendocrine tumours independent of small-cell and large-cell neuroendocrine carcinomas identified by gene expression profiles. Lancet 2004 363 775 781
26. Bhattacharjee A, Richards WG, Staunton J, Classification of human lung carcinomas by mRNA expression profiling reveals distinct adenocarcinoma subclasses. Proc Natl Acad Sci USA 2001 98 13790 13795
27. DuPage M, Dooley AL, Jacks T, Conditional mouse lung cancer models using adenoviral or lentiviral delivery of Cre recombinase. Nat Protoc 2009 4 1064 1072
28. Pritt BS, Cooper K, The Azzopardi phenomenon. Arch Pathol Lab Med 2003 127 1231
29. Augustyn A, Borromeo M, Wang T, ASCL1 is a lineage oncogene providing therapeutic targets for high-grade neuroendocrine lung cancers. Proc Natl Acad Sci USA 2014 111 14788 14793
30. Linnoila RI, Naizhen X, Meuwissen R, Berns A, DeMayo FJ, Mouse lung neuroendocrine carcinomas: Distinct morphologies, same transcription factors. Exp Lung Res 2005 31 37 55
31. Linnoila RI, Zhao B, DeMayo JL, Constitutive achaete-scute homologue-1 promotes airway dysplasia and lung neuroendocrine tumors in transgenic mice. Cancer Res 2000 60 4005 4009
32. Linnoila RI, Sahu A, Miki M, Ball DW, DeMayo FJ, Morphometric analysis of CC10-hASH1 transgenic mouse lung: A model for bronchiolization of alveoli and neuroendocrine carcinoma. Exp Lung Res 2000 26 595 615
33. Inoue K, Fry E, Maglic D, Kayembe J-M, Genetically engineered mouse models for human lung cancer. Oncogenesis, Inflammatory and Parasitic Tropical Diseases of the Lung 2013 29 60
34. Politi K, Pao W, How genetically engineered mouse tumor models provide insights into human cancers. J Clin Oncol 2011 29 2273 2281
35. Pleasance ED, Stephens PJ, O'Meara S, A small-cell lung cancer genome with complex signatures of tobacco exposure. Nature 2010 463 184 190
36. Dooley AL, Winslow MM, Chiang DY, Nuclear factor I/B is an oncogene in small cell lung cancer. Genes Dev 2011 25 1470 1475
37. Huijbers IJ, Bin Ali R, Pritchard C, Rapid target gene validation in complex cancer mouse models using re-derived embryonic stem cells. EMBO Mol Med 2014 6 212 225
38. Meuwissen R, Berns A, Mouse models for human lung cancer. Genes Dev 2005 19 643 664
39. Reynolds SD, Giangreco A, Power JH, Stripp BR, Neuroepithelial bodies of pulmonary airways serve as a reservoir of progenitor cells capable of epithelial regeneration. Am J Pathol 2000 156 269 278
40. Sun S, Schiller JH, Gazdar AF, Lung cancer in never smokers-A different disease. Nat Rev Cancer 2007 7 778 790
41. Sutherland KD, Proost N, Brouns I, Adriaensen D, Song JY, Berns A, Cell of origin of small cell lung cancer: Inactivation of Trp53 and Rb1 in distinct cell types of adult mouse lung. Cancer Cell 2011 19 754 764
42. Nikitin AY, Alcaraz A, Anver MR, Classification of proliferative pulmonary lesions of the mouse: recommendations of the mouse models of human cancers consortium. Cancer Res 2004 64 2307 2316
43. Shmidt EN, Nitkin AY, Pathology of mouse models of human lung cancer. Comp Med 2004 54 23 26
44. Kwon MC, Berns A, Mouse models for lung cancer. Mol Oncol 2013 7 165 177
45. Böck BC, Stein U, Schmitt CA, Augustin HG, Mouse models of human cancer. Cancer Res 2014 74 4671 4675
46. Xiao Z, Jiang Q, Willette-Brown J, The pivotal role of IKKα in the development of spontaneous lung squamous cell carcinomas. Cancer Cell 2013 23 527 540